| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |